David Guinovart, PhD, and Eric Rahrmann, PhD, assistant professors at The Hormel Institute, University of Minnesota, are the recipients of a two-year, $100,000 Data Science Initiative (DSI) Seed Grant from the University of Minnesota.  Their funded project, MOOBI: Multi-Omics Optimization-Based Int egration for Enhanced Cancer Research Datasets, aims to tackle key challenges in integrating multi-omics data for more precise breast cancer diagnosis and therapeutic targets. Multi-omics is a biological analysis approach that makes use of multiple types of datasets. In this project, Guinovart and team are leveraging data made publicly available from The Cancer Genome Atlas (TCGA). They aim to develop a new, integrated dataset with the ultimate goal of enhancing breast cancer subtype classifications and identifying biomarkers for diagnosis and therapeutic targets. This means patients could have a higher likelihood of being matched with the right treatment options for the right cancer as early as possible. With his background in applied mathematics, Guinovart sought Rahrmann’s expertise in cancer biology and metastasis for this interdisciplinary collaboration.  “The way we see this collaboration is an integrative process: we develop an idea, Eric will offer his ideas, and we will adjust as needed. It keeps the model not only accurate, but also fresh,” Guinovart said. “In this particular case, we are trying to add more information to this already available data, developing a model that can respond to real-life problems more effectively. I think this could be used for other opportunities, but we will also have a clean dataset that has been validated at another level. We will also be able to share this ready-to-use data to fit other models, ideas, or research.”  With Guinovart an applied mathematician and Rahrmann an expert in developmental biology, cancer biology and metastasis, this endeavor is a collaboration that helps keep the ideas considered and models developed accurate and fresh.  “Too often, we only look at the tip of the iceberg and ignore the rest of the data. Essentially, we’re going back with these new, innovative approaches to revisit old questions and ultimately identify new biomarkers and therapeutic targets,” Rahrmann said.  The project also holds potential for broader applications in the future. Rahrmann said that the data may be helpful in identifying transition phases of cancer toward hybrid cancer types at critical times of disease progression. The TCGA has a treasure trove of data — 2.5 petabytes, in fact, or 2.5 million gigabytes — that has been gathered over decades of research. With so much information at hand, projects like this can find new connections and applications that have yet to be discovered. Once the research team has its refined, well-structured data, they will feed that data to machine learning models that use multiple parameters for optimized classification to minimize false positives in cancer diagnosis as much as possible. Post-Doctoral Associate Mohammed Qaraad, PhD, and Senior Scientist Kayum Alam, PhD, are also contributing to the project. The post Institute scientists are optimizing data for more precise cancer diagnosis, treatment appeared first on Austin Daily Herald. ...read more read less